Page last updated: 2024-08-21

pyrazines and Infection Reactivation

pyrazines has been researched along with Infection Reactivation in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chang, X; Chen, G; Chen, X; Du, W; Gong, B; Ji, Y; Jiang, X; Jiang, Y; Li, G; Li, J; Li, N; Li, W; Liu, Y; Peng, P; Sun, W; Wang, G; Wang, Y; Wu, Z; Xiao, Z; Yao, J; Zeng, Q; Zhang, C; Zhao, H; Zhu, F; Zhu, Q	1

Trials

1 trial(s) available for pyrazines and Infection Reactivation

Article	Year
Favipiravir in the treatment of patients with SARS-CoV-2 RNA recurrent positive after discharge: A multicenter, open-label, randomized trial. International immunopharmacology, 2021, Volume: 97 Topics: Administration, Oral; Adult; Aged; Amides; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Female; Humans; Lymphocyte Subsets; Male; Middle Aged; Patient Discharge; Pyrazines; Reinfection; RNA, Viral; SARS-CoV-2; Treatment Outcome	2021

Article

Year

Favipiravir in the treatment of patients with SARS-CoV-2 RNA recurrent positive after discharge: A multicenter, open-label, randomized trial.

International immunopharmacology, 2021, Volume: 97

Topics: Administration, Oral; Adult; Aged; Amides; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Female; Humans; Lymphocyte Subsets; Male; Middle Aged; Patient Discharge; Pyrazines; Reinfection; RNA, Viral; SARS-CoV-2; Treatment Outcome

2021